Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy

類似資料

• Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
  著者:: Kaleda, Maria I, 等
  出版事項: (2014)
• An experience of sequental use of three biologics and recombinant growth hormone in a patient with juvenile idiopathic arthritis associated with unsuccessful outcome of hip damage
  著者:: Nikishina, IP, 等
  出版事項: (2011)
• THE PHENOMENON OF NEUTROPENIA DURING TOCILIZUMAB THERAPY IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
  著者:: M. I. Kaleda, 等
  出版事項: (2018-01-01)
• Growth disturbance problem in patients with juvenile rheumatoid arthritis
  著者:: A N Shapovalenko, 等
  出版事項: (2007-10-01)
• PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
  著者:: Stepanenko, N, 等
  出版事項: (2013)